evaluating the impact of a switch to nilotinib on imatinib-related chronic low-grade adverse events in patients with cml-cp the enrich study
本文档由 qgn744251 分享于2017-04-21 12:17
evaluating the impact of a switch to nilotinib on imatinib-related chronic low-grade adverse events in patients with cml-cp the enrich study
分享:
君,已阅读到文档的结尾了呢~~